DMD Large equally mixed donor pool

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Drug Metabolism and Disposition Fast Forward
First published on July 20, 2005; DOI: 10.1124/dmd.105.004663


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
dmd.105.004663v1
33/10/1513    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Miles, K. K.
Right arrow Articles by Ritter, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miles, K. K.
Right arrow Articles by Ritter, J.


Received for publication March 18, 2005.
Revised June 27, 2005.
Accepted for publication July 15, 2005.

AN INVESTIGATION OF HUMAN AND RAT LIVER MICROSOMAL MYCOPHENOLIC ACID GLUCURONIDATION: EVIDENCE FOR A PRINCIPAL ROLE OF UGT1A ENZYMES AND SPECIES DIFFERENCES IN UGT1A SPECIFICITY

Kristini K. Miles 1, Stephan T. Stern 2, Philip C. Smith 2, Fay Kessler 1, Shazia Ali 2, Joe Ritter 1*

1 Virginia Commonwealth University 2 University of North Carolina Chapel Hill

* Address correspondence to: E-mail: jkritter{at}vcu.edu

Abstract

Mycophenolic acid (MPA), the active metabolite of the immunosuppressant prodrug, mycophenolate mofetil, undergoes glucuronidation to its 7-O-glucuronide as a primary route of metabolism. Because differences in glucuronidation may influence the efficacy and/or toxicity of MPA, we investigated the MPA UDP-glucuronosyltransferase (UGT) activities of human (HLM) and rat liver microsomes with the goal of identifying UGTs responsible for MPA catalysis. HLM (n=23) exhibited higher average MPA glucuronidation rates (14.7 vs. 6.0 nmol/mg/min, respectively, p<0.001) and higher apparent affinity for MPA (Km = 0.082 mM vs. 0.20 mM, p< 0.001) compared to rat liver microsomes. MPA UGT activities were reduced >80% in liver microsomes from Gunn rats. To identify the active enzymes, human and rat UGT1A enzymes were screened for MPA glucuronidating activity. UGT1A9 was the only human liver-expressed UGT1A enzyme with significant activity and exhibited both high affinity (Km= 0.077 mM) and high activity (Vmax= 28 nmol•min-1•mg-1). Spearman correlation analyses revealed a stronger relationship between HLM MPA UGT activities and 1A9-like content (r2=0.79) relative to 1A1 (r2=0.20), 1A4-like (r2=0.22), and 1A6 (r2=0.41) protein. A different profile was observed for rat with three active liver-expressed UGT1A enzymes: 1A1 (medium affinity/capacity), 1A6 (low affinity/medium capacity), and 1A7 (high affinity/capacity). Our data suggest that UGT1A enzymes are the major contributors to hepatic MPA metabolism in both species, but 1A9 is dominant in human while 1A1 and 1A7 are likely the principal mediators in control rat liver. This information should be useful for interpretation of MPA pharmacokinetic and toxicity data in clinical and animal studies.


Key words: enzyme kinetics, glucuronidation, hepatic elimination, liver microsomes, microsomes, UDP glucuronyltransferases


This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
H. Shiratani, M. Katoh, M. Nakajima, and T. Yokoi
Species Differences in UDP-Glucuronosyltransferase Activities in Mice and Rats
Drug Metab. Dispos., September 1, 2008; 36(9): 1745 - 1752.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
S. T. Stern, M. N. Tallman, K. K. Miles, J. K. Ritter, and P. C. Smith
Androgen Regulation of Renal Uridine Diphosphoglucuronosyltransferase 1A1 in Rats
Drug Metab. Dispos., September 1, 2008; 36(9): 1737 - 1739.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
I. S. Westley, R. G. Morris, A. M. Evans, and B. C. Sallustio
Glucuronidation of Mycophenolic Acid by Wistar and Mrp2-Deficient TR- Rat Liver Microsomes
Drug Metab. Dispos., January 1, 2008; 36(1): 46 - 50.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
J. Ramirez, W. Liu, S. Mirkov, A. A. Desai, P. Chen, S. Das, F. Innocenti, and M. J. Ratain
Lack of Association between Common Polymorphisms in UGT1A9 and Gene Expression and Activity
Drug Metab. Dispos., December 1, 2007; 35(12): 2149 - 2153.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
S. T. Stern, M. N. Tallman, K. K. Miles, J. K. Ritter, R. E. Dupuis, and P. C. Smith
Gender-Related Differences in Mycophenolate Mofetil-Induced Gastrointestinal Toxicity in Rats
Drug Metab. Dispos., March 1, 2007; 35(3): 449 - 454.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
K. K. Miles, F. K. Kessler, P. C. Smith, and J. K. Ritter
Characterization of Rat Intestinal Microsomal UDP-Glucuronosyltransferase Activity toward Mycophenolic Acid
Drug Metab. Dispos., September 1, 2006; 34(9): 1632 - 1639.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
K. K. Miles, F. K. Kessler, L. J. Webb, P. C. Smith, and J. K. Ritter
Adenovirus-Mediated Gene Therapy to Restore Expression and Functionality of Multiple UDP-Glucuronosyltransferase 1A Enzymes in Gunn Rat Liver
J. Pharmacol. Exp. Ther., September 1, 2006; 318(3): 1240 - 1247.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
C. Yu, J. K. Ritter, R. J. Krieg, B. Rege, T. H. Karnes, and M. A. Sarkar
EFFECT OF CHRONIC RENAL INSUFFICIENCY ON HEPATIC AND RENAL UDP-GLUCURONYLTRANSFERASES IN RATS
Drug Metab. Dispos., April 1, 2006; 34(4): 621 - 627.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics.